🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7635683

Quinoxalinyl tripeptide hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7625913

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622610

Crystalline ACAT inhibitor

Graceway Pharmaceuticals. LLC · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622463

Dihydrodiazepines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618936

Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)

The Regents of the University of California · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7615573

Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612091

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612065

Inhibitors of c-JUN N-terminal kinases (JNK)

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608632

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608422

Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhib

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605126

Acylaminoheteroaryl hepatitis C virus protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601718

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601713

Kinase inhibitors and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601709

Macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598277

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598245

Aminotriazole compounds useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7595326

Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analo

Champions Biotechnology, Inc · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592368

Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592343

Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592340

Quinoxalines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589220

Inhibitors of the anandamide transporter

UNIVERSITY OF CONNECTICUT · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589214

Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585844

Myosin light chain kinase inhibitors and methods of use

University College Cardiff Consultants Limited · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585842

Human kunitz-type inhibitor with enhanced antifibrinolytic activity

The Regents of the University of California · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted